Provent Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Provent Phase. Real-time updates on events, politics, business and more.

Evusheld reduces risk of symptomatic COVID-19 in high-risk population

April 21, 2022

Phase III trial shows Evusheld (tixagevimab and cilgavimab) reduces the risk of developing symptomatic COVID-19 in vulnerable populations.

Source: europeanpharmaceuticalreview.com

December 9, 2021

TOP NEWS: Astras Covid-19 antibody drug Evusheld gets approval in US | Financial News

Source: lse.co.uk

August 20, 2021

LONDON BRIEFING: Softbanks Fortress doesnt give up on Morrisons | Financial News

Source: lse.co.uk

August 20, 2021

LONDON MARKET PRE-OPEN: Astra works on Covid cocktail; UK sales falter | Financial News

Source: lse.co.uk